Professor, Department of Obstetrics and Gynaecology ; Deputy Director, Prenatal Genetic Diagnosis Centre, CUHK; Director, Pre-implantation Genetic Diagnosis Laboratory, CUHK
Advancements in technologies have revolutionized the genetic landscape. Chromosomal microarray analysis (CMA) becomes a proven method and is implemented to detect gains and losses of DNA and absence of heterozygosity across the genome. Next-generation sequencing technologies have brought opportunities and challenges to genetic testing, its prenatal application is an emerging field. We describe our experience using FetalChip, a CMA for prenatal research developed in our laboratory and describe the role of CMA in the era of genome sequencing.
Learning Objectives
The role of chromosomal microarray analysis (CMA) in prenatal genetic clinical research.
CMA is a well-established and proven technology to identify pathogenic CNVs
The utility of genome sequencing
For Research Use Only. Not for use in diagnostic procedures.
Webinars will be available for unlimited on-demand viewing after live event.
Even in the most controlled labs, balance performance can drift — electrostatics, air drafts, temperature shifts, or even the way samples are handled can quietly undermine your results...
Unlock the full potential of your LC-MS system with Thermo Scientific™ Chromeleon™ software features. This webinar will demonstrate the system suitability test with intelligent r...
Research in plant and animal genomics often involve complex genetic challenges that require tailored approaches. From addressing genetic complexity in aquaculture species to investigating tr...
Do you use pipettes in your daily work? Want to improve your pipetting accuracy? To eliminate the guesswork, METTLER TOLEDO Rainin developed Good Pipetting Practice™ (GPP™) as a...
BACKGROUND . Myelodysplastic syndromes (MDS) are a heterogeneous group of myeloid neoplasms with variable clinical outcomes and an increased risk of progression to Acute Myeloid Leukemia (AM...